Address: Loire 150
Gebouw Castellum, ingang C (Synthesium)
2491 AK Den Haag,Netherlands
Tel: +31 (0) 70 337 87 64
Web: http://www.niaba.nl/website/
For over twenty years, the Netherlands Biotech Industry Association (Niaba) has brought together more than seventy of its home country’s biggest and finest biotech-related companies en organizations. Its members operate in fields such as human and animal health, food, feed, agriculture and the environment.
Niaba counts large, globally operating companies such as Unilever, DSM, and Schering-Plough among its members. However, the association also involves small biotech companies, research institutions and other associations operating in adjacent fields.
Niaba informs and lobbies governments and public media on a host of biotech-related issues, helping to build and maintain a business climate that welcomes biotechnology as a way to make people’s lives better and economies more sustainable.
The Netherlands is known for its open-minded and highly productive life sciences business climate, thanks in part to a solid regulatory and legal system. The Dutch government has been instrumental in bringing together public and private efforts towards research and development, for example by creating extensively funded public-private partnership programs.
Niaba works to improve on this highly productive business climate for the life sciences even further.
As an associaton, Niaba is governed by and to the benefit of its members. Together, they identify policy priorities for the business sector as a whole. Expert committees help to frame priorities and support the bureau in carrying out all the associaton’s policies.
The European Union is increasingly important for the climate in which biotech-related organisations and companies operate. Ever more regulation, for example, stems from EU directives and regulations. Niaba therefore also operates in Brussels, the heart of the EU. Niaba is represented in the board and the executive commitee of EuropaBio, the European biotechnology association. Niaba chairs the National Associations Council, a body in which national business associations work together.
The Netherlands is famous throughout Europe and the global pharmaceutical community for its research infrastructure – institutes, university hospitals, and public private partnerships. Given this foundation and the size of…
Floris Van Haselen, Business Development Director Europe for O&M Movianto, one of the rare logistics companies to be fully specialized and to only operate in the healthcare sector, explains how the company…
Peter Schoevers, CEO and co-founder of Julius Clinical, explains how this innovative and thriving organization allies the academic strength of an ARO with the business-oriented leadership of a CRO. Julius…
Isabelle de Walsche, Managing Director of Gedeon Richter Benelux, provides us with an update on the development of this striving and ambitious player in the women’s healthcare field and shares…
Roeland Van Dam, CEO of Bilthoven Biologicals, a historical Dutch company which remains at the forefront of vaccine production, explains how being integrated into the Serum Institute of India has…
Rob de Roock, Director CL Healthcare for UPS Europe, gives us a brief outline of the current market dynamics impacting the booming European healthcare logistics industry and explains how UPS…
Han Brouwer, General Manager for Actelion in the Netherlands, explains how Opsumit’s successful market launch has strengthened Actelion’s leadership position in the pulmonary arterial hypertension (PAH) field. He calls for…
Bart van de Kerkhof highlights how Covidien’s acquisition will drive Medtronic to new heights thanks to a broader product portfolio. Medtronic is already piloting projects and cooperating with key stakeholders to…
Anita Atema, General Manager of Celgene, reveals Celgene’s inspiring and concrete initiatives that illustrate how a true willingness to cooperate with healthcare stakeholders and a remarkable effort of transparency can help…
Amgen Netherlands is preparing to launch five new products next year, including their leading cardiovascular biotech product Repatha and recently announced the acquisition of the Dutch biotech Dezima. General manager…
Maikel Beerens, CEO and founder of Xilloc, a promising Dutch company that designs patient-specific implants, anatomical models and surgical guides for bone reconstruction or augmentation with the help of 3-D…
Michiel van der Veen, CEO of GenKey, a global player in biometric identity management based in Eindhoven, explains how both the healthcare industry and public health schemes could benefit from…
Menno Kok and Roel Kamerling, Director and CIO of Medical Delta, a life sciences, health & technology innovation cluster around Leiden, Delft and Rotterdam in the West of the Netherlands,…
See our Cookie Privacy Policy Here
